Researchers investigated COVID-19 diagnoses and related hospitalization or death in dialysis patients. A whole food, plant-based diet has shown benefits for patients with chronic kidney disease (CKD). Medicare Part D spending on GLP-1 drugs has soared to $5.7 billion, straining Medicare spending. APRIL has emerged as a critical factor in the pathogenesis of IgAN and is the focus of several clinical development programs. Studies have suggested physical activity has beneficial effects on health-related outcomes in kidney transplant patients. AstraZeneca has removed tozorakimab from its phase 2 pipeline for diabetic kidney disease. Researchers examined racial differences in rates of living donor kidney transplant, including center characteristics. A study examined the association of COVID-19 disease vs vaccination with kidney function and glomerular disease activity. Potential living kidney donors may be unprepared for possible negative outcomes following donation. The study analyzed data from 185 countries using the GLOBOCAN 2020 statistics.